Nancy Kemeny

3.0k total citations · 1 hit paper
32 papers, 2.4k citations indexed

About

Nancy Kemeny is a scholar working on Oncology, Surgery and Hepatology. According to data from OpenAlex, Nancy Kemeny has authored 32 papers receiving a total of 2.4k indexed citations (citations by other indexed papers that have themselves been cited), including 20 papers in Oncology, 14 papers in Surgery and 11 papers in Hepatology. Recurrent topics in Nancy Kemeny's work include Hepatocellular Carcinoma Treatment and Prognosis (11 papers), Colorectal Cancer Treatments and Studies (10 papers) and Colorectal Cancer Surgical Treatments (6 papers). Nancy Kemeny is often cited by papers focused on Hepatocellular Carcinoma Treatment and Prognosis (11 papers), Colorectal Cancer Treatments and Studies (10 papers) and Colorectal Cancer Surgical Treatments (6 papers). Nancy Kemeny collaborates with scholars based in United States, Netherlands and Germany. Nancy Kemeny's co-authors include Leonard B. Saltz, Michael I. D’Angelica, Elin R. Sigurdson, Bruce D. Minsky, Nicholas W. Gale, David Jin, Sergey V. Shmelkov, Jason M. Butler, Amy Chadburn and Adı́lia Hormigo and has published in prestigious journals such as Journal of Clinical Investigation, Journal of Clinical Oncology and Blood.

In The Last Decade

Nancy Kemeny

32 papers receiving 2.3k citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

CD133 expression is not restricted to stem cells, and both CD133+ and CD133– metastatic colon cancer cells initiate tumors

2008 731 citations Sergey V. Shmelkov, Jason M. Butler et al. Journal of Clinical Investigation profile →

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Nancy Kemeny United States	20	1.8k	834	578	526	375	32	2.4k
Luca Emanuele Pollina Italy	22	1.1k 0.6×	418 0.5×	750 1.3×	495 0.9×	417 1.1×	63	2.1k
David G. Heidt United States	15	2.4k 1.3×	624 0.7×	1.8k 3.1×	321 0.6×	291 0.8×	22	3.7k
Yukishige Yamada Japan	19	1.2k 0.7×	541 0.6×	857 1.5×	150 0.3×	652 1.7×	46	2.3k
Naoki Ikenaga Japan	25	962 0.5×	605 0.7×	830 1.4×	507 1.0×	285 0.8×	75	2.3k
John A. Conti United Kingdom	14	1.1k 0.6×	619 0.7×	189 0.3×	675 1.3×	305 0.8×	25	1.6k
Hiroyuki Shinchi Japan	28	1.7k 0.9×	753 0.9×	680 1.2×	222 0.4×	594 1.6×	105	2.7k
Arantza Fariña Sarasqueta Netherlands	22	1.0k 0.6×	383 0.5×	437 0.8×	182 0.3×	366 1.0×	83	1.8k
Alfred Cohen United States	17	1.3k 0.7×	827 1.0×	210 0.4×	600 1.1×	353 0.9×	30	1.8k
Todd S. Crocenzi United States	23	1.6k 0.9×	461 0.6×	269 0.5×	645 1.2×	541 1.4×	59	2.3k
Takushi Monden Japan	28	1.1k 0.6×	686 0.8×	1.1k 1.8×	97 0.2×	537 1.4×	146	2.6k

Countries citing papers authored by Nancy Kemeny

Since Specialization

Citations

This map shows the geographic impact of Nancy Kemeny's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Nancy Kemeny with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Nancy Kemeny more than expected).

Fields of papers citing papers by Nancy Kemeny

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Nancy Kemeny. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Nancy Kemeny. The network helps show where Nancy Kemeny may publish in the future.

Co-authorship network of co-authors of Nancy Kemeny

This figure shows the co-authorship network connecting the top 25 collaborators of Nancy Kemeny. A scholar is included among the top collaborators of Nancy Kemeny based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Nancy Kemeny. Nancy Kemeny is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Kurilova, Ieva, Geerard L. Beets, Jessica Flynn, et al.. (2018). Factors Affecting Oncologic Outcomes of 90Y Radioembolization of Heavily Pre-Treated Patients With Colon Cancer Liver Metastases. Clinical Colorectal Cancer. 18(1). 8–18. 28 indexed citations

Cercek, Andrea, Maria Ignez Braghiroli, Joanne F. Chou, et al.. (2017). Clinical Features and Outcomes of Patients with Colorectal Cancers Harboring NRAS Mutations. Clinical Cancer Research. 23(16). 4753–4760. 58 indexed citations

Soff, Gerald A., Yimei Miao, Sean M. Devlin, et al.. (2017). Romiplostim for Chemotherapy-Induced Thrombocytopenia (CIT). Results of a Phase 2 Trial. Blood. 130. 289–289. 5 indexed citations

Cercek, Andrea, Salma K. Jabbour, Dirk F. Moore, et al.. (2017). A Comparison of Yttrium-90 Microsphere Radioembolization to Hepatic Arterial Infusional Chemotherapy for Patients with Chemo-refractory Hepatic Colorectal Metastases. Current Treatment Options in Oncology. 18(7). 42–42. 3 indexed citations

Correa‐Gallego, Camilo, Danilo Maddalo, Alexandre Doussot, et al.. (2016). Circulating Plasma Levels of MicroRNA-21 and MicroRNA-221 Are Potential Diagnostic Markers for Primary Intrahepatic Cholangiocarcinoma. PLoS ONE. 11(9). e0163699–e0163699. 50 indexed citations

Sadot, Eran, Bas Groot Koerkamp, Julie N. Leal, et al.. (2015). Resection Margin and Survival in 2368 Patients Undergoing Hepatic Resection for Metastatic Colorectal Cancer. Annals of Surgery. 262(3). 476–485. 138 indexed citations

Urosevic, Jelena, Xabier García‐Albéniz, Evarist Planet, et al.. (2014). Colon cancer cells colonize the lung from established liver metastases through p38 MAPK signalling and PTHLH. Nature Cell Biology. 16(7). 685–694. 114 indexed citations

Humeniuk, Rita, Lata G. Menon, Prasun Mishra, et al.. (2009). Decreased levels of UMP kinase as a mechanism of fluoropyrimidine resistance. Molecular Cancer Therapeutics. 8(5). 1037–1044. 43 indexed citations

Shmelkov, Sergey V., Jason M. Butler, Andrea T. Hooper, et al.. (2008). CD133 expression is not restricted to stem cells, and both CD133+ and CD133– metastatic colon cancer cells initiate tumors. Journal of Clinical Investigation. 118(6). 2111–20. 731 indexed citations breakdown →

10.

Kemeny, Nancy & Farid Fata. (2001). Hepatic-arterial chemotherapy. The Lancet Oncology. 2(7). 418–428. 48 indexed citations

11.

Sgouros, George, Joseph A. O’Donoghue, Steven M. Larson, et al.. (1998). Mathematical model of 5-[125I]iodo-2′-deoxyuridine treatment: continuous infusion regimens for hepatic metastases. International Journal of Radiation Oncology*Biology*Physics. 41(5). 1177–1183. 4 indexed citations

12.

Grann, Alison, Bruce D. Minsky, Alfred M. Cohen, et al.. (1997). Preliminary results of preoperative 5-fluorouracil, low-dose leucovorin, and concurrent radiation therapy for clinically resectable T3 rectal cancer. Diseases of the Colon & Rectum. 40(5). 515–522. 195 indexed citations

13.

Cohen, Alfred M., Warren E. Enker, David P. Kelsen, et al.. (1994). Preoperative 5-fluorouracil, low-dose leucovorin, and concurrent radiation therapy for rectal cancer. Cancer. 73(2). 273–280. 112 indexed citations

14.

Conti, Jessica, Nancy Kemeny, Karen Seiter, et al.. (1994). Trial of sequential trimetrexate, fluorouracil, and high-dose leucovorin in previously treated patients with gastrointestinal carcinoma.. Journal of Clinical Oncology. 12(4). 695–700. 35 indexed citations

15.

Minsky, Bruce D., A. M. Cohen, Nancy Kemeny, et al.. (1992). Enhancement of radiation-induced downstaging of rectal cancer by fluorouracil and high-dose leucovorin chemotherapy.. Journal of Clinical Oncology. 10(1). 79–84. 204 indexed citations

16.

Kemeny, Nancy, Karen Seiter, Donna Niedzwiecki, et al.. (1992). A randomized trial of intrahepatic infusion of fluorodeoxyuridine with dexamethasoneversus fluorodeoxyuridine alone in the treatment of metastatic colorectal cancer. Cancer. 69(2). 327–334. 179 indexed citations

17.

O’Boyle, Kevin & Nancy Kemeny. (1989). Synchronous colon and renal cancers: Six cases of a clinical entity. The American Journal of Medicine. 87. 691–693. 2 indexed citations

18.

Schneider, Andrew M., et al.. (1989). Intrahepatic mitomycin C as a salvage treatment for patients with hepatic metastases from colorectal carcinoma. Cancer. 64(11). 2203–2206. 7 indexed citations

19.

Frame, James D., et al.. (1988). A Phase II Trial of Streptozotocin and Adriamycin in Advanced APUD Tumors. American Journal of Clinical Oncology. 11(4). 490–495. 27 indexed citations

20.

Needles, Burton, Nancy Kemeny, & Carlos Urmacher. (1981). Malignant thymoma: Renal metastases responding to cis-platinum. Cancer. 48(2). 223–226. 27 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact